STOCK TITAN

Hercules Capital Inc - HTGC STOCK NEWS

Welcome to our dedicated page for Hercules Capital news (Ticker: HTGC), a resource for investors and traders seeking the latest updates and insights on Hercules Capital stock.

Hercules Capital, Inc. (NYSE: HTGC) is a premier specialty finance company dedicated to providing senior secured loans to high-growth, venture capital-backed companies in technology-related markets. Established in December 2003, Hercules has positioned itself as a key player in the venture lending space, committing over $4.6 billion to more than 300 companies across various stages of development. The company focuses on sectors such as technology, biotechnology, life sciences, and sustainable and renewable energy.

Hercules Capital stands out by offering more than just financial support. The company provides vital access to its expansive network of contacts and invaluable business advice, helping entrepreneurial companies achieve significant milestones. Their investment portfolio includes a mix of structured debt with warrants, senior debt, and equity investments.

Recent achievements include a $35 million loan facility to SynOx Therapeutics Limited to support the development of emactuzumab, a next-generation monoclonal antibody for treating Tenosynovial Giant Cell Tumour (TGCT). Another notable investment is the $150 million financing to Harness, a Modern Software Delivery Platform company, to expand its platform with new modules and enhance its use of generative AI.

Hercules Capital’s strategic partnerships and financial solutions make it the lender of choice for venture-backed companies seeking reliable growth capital. The company’s financial stability and extensive industry expertise ensure that it remains a trusted partner for innovation-driven businesses looking to scale.

Rhea-AI Summary

Hercules Capital, Inc. (NYSE: HTGC) announced its participation in the Piper Sandler Western Financial Services Conference on March 8, 2022, in San Diego, CA. The company is a leading specialty financing provider focused on delivering senior secured venture growth loans to innovative, venture capital-backed firms. Since inception, Hercules has committed over $13 billion to more than 560 companies. Hercules also operates an asset management business through Hercules Adviser LLC, which manages investments for external parties.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.5%
Tags
none
-
Rhea-AI Summary

Hercules Capital reported record financial results for the fourth quarter and full-year 2021, announcing total gross debt and equity commitments of $2.64 billion, up 122.1% year-over-year. Q4 gross fundings reached $503.3 million, while net investment income for Q4 was $0.35 per share, offering 106% coverage of base distributions. The company declared a new $0.60 supplemental distribution, payable quarterly starting March 2022. Additionally, undistributed earnings spillover amounted to $192.1 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.74%
Tags
-
Rhea-AI Summary

Hercules Capital has declared a new supplemental cash distribution of $0.60 per share, to be distributed over four quarters, starting with $0.15 for Q4 2021. This is an increase from the previously declared $0.07 per share. The record date for this distribution is March 9, 2022, and the payment date is March 16, 2022. Hercules aims to distribute 90%-100% of its taxable income annually, benefiting shareholders through regular and supplemental distributions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.62%
Tags
none
Rhea-AI Summary

Hercules Capital (NYSE: HTGC) announced a cash distribution of $0.33 per share for the fourth quarter of 2021, with a record date of March 9, 2022 and a payment date of March 16, 2022. The company maintains a variable distribution policy aimed at distributing 90% to 100% of its taxable income annually. For Q4 2021, 88.3% of declared distributions were classified as Qualified Interest Income (QII), potentially exempt from U.S. withholding tax for foreign shareholders. Hercules has committed over $13 billion to more than 540 companies since its inception in 2003.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.62%
Tags
none
-
Rhea-AI Summary

Hercules Capital (NYSE: HTGC) has scheduled its fourth quarter and full-year 2021 financial results conference call for February 22, 2022, at 2:00 p.m. PT. Financial results will be released after market close on the same day. Investors can join the call by dialing (877) 304-8957, with access to a taped replay available for seven days. Hercules Capital, the largest specialty finance company providing venture growth loans, has committed over $13 billion to more than 540 companies since its inception in December 2003. The company also manages investments through Hercules Adviser LLC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.83%
Tags
-
Rhea-AI Summary

Hercules Capital (NYSE: HTGC) has announced key internal promotions and a new addition to its executive management team. Christian Follmann has been promoted to Chief Operating Officer, Charlie Vandis to Chief Credit Officer, and Kiersten Zaza Botelho has joined as General Counsel and Chief Compliance Officer. The CEO, Scott Bluestein, emphasized the importance of these moves to enhance the company's capabilities and market position in venture and growth stage lending. Hercules has committed over $13 billion to more than 540 companies since its inception in 2003.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.22%
Tags
none
Rhea-AI Summary

Hercules Capital (NYSE: HTGC) has successfully closed an underwritten public offering of $350 million in 3.375% notes due January 2027. Proceeds will be used to repay existing convertible notes, support investments, and for general corporate purposes. Moody’s assigned a Baa3 rating while Kroll rated it BBB+. The notes are unsecured, pay interest semiannually, and may be redeemed early at par plus a potential premium.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.03%
Tags
-
Rhea-AI Summary

Hercules Capital has priced an underwritten public offering of $350 million in 3.375% notes maturing on January 20, 2027. The offering is subject to customary conditions and expected to close on January 20, 2022. Proceeds will be used to repay 4.375% convertible notes due 2022, fund investments, and for general corporate purposes. The company has committed over $13 billion since its inception in December 2003, focusing on growth loans for venture-backed companies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.91%
Tags
-
Rhea-AI Summary

NorthSea Therapeutics B.V. has successfully closed a USD 80 million Series C financing round, co-led by Ysios Capital and Forbion Growth. New investors include Hercules Capital. The funds will enhance the development of their pipeline focused on treating non-alcoholic steatohepatitis (NASH) and other metabolic diseases. The lead product, Icosabutate, has shown promising results in ongoing clinical trials, with plans to advance into phase 3 next year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.37%
Tags
none
Rhea-AI Summary

Hercules Capital (NYSE: HTGC) has achieved a record $2.0 billion in gross debt and equity commitments year-to-date, surpassing its previous record of $1.47 billion. This milestone is attributed to the company's robust venture and growth stage lending platform and diverse strategies. CEO Scott Bluestein highlighted the importance of quality team dynamics and disciplined underwriting for long-term success. Hercules has committed over $13 billion since its inception in 2003 and continues to lead in providing growth loans to innovative companies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.18%
Tags
none

FAQ

What is the current stock price of Hercules Capital (HTGC)?

The current stock price of Hercules Capital (HTGC) is $21.47 as of February 21, 2025.

What is the market cap of Hercules Capital (HTGC)?

The market cap of Hercules Capital (HTGC) is approximately 3.8B.

What does Hercules Capital, Inc. specialize in?

Hercules Capital specializes in providing senior secured loans to venture capital-backed companies in technology-related industries.

Which industries does Hercules Capital, Inc. focus on?

Hercules Capital focuses on technology, biotechnology, life sciences, and sustainable and renewable energy sectors.

How much has Hercules Capital, Inc. committed since its inception?

Since its inception in December 2003, Hercules Capital has committed over $4.6 billion to more than 300 companies.

What kind of financial products does Hercules Capital, Inc. offer?

Hercules Capital offers a mix of structured debt with warrants, senior debt, and equity investments.

Can you provide an example of a recent investment by Hercules Capital, Inc.?

A recent investment by Hercules Capital includes a $35 million loan facility to SynOx Therapeutics Limited for developing emactuzumab.

Why do companies choose Hercules Capital, Inc.?

Companies choose Hercules Capital for its reliable growth capital, access to an extensive network of contacts, and valuable business advice.

How does Hercules Capital, Inc. support its portfolio companies beyond financial investment?

Beyond financial investment, Hercules Capital offers access to a wide network of contacts and essential business advice to help companies achieve key milestones.

What is a notable recent achievement of Hercules Capital, Inc.?

A notable recent achievement is the $150 million financing to Harness to support the expansion of their software delivery platform.

How does Hercules Capital, Inc. ensure its financial stability?

Hercules ensures financial stability through strategic partnerships, diversified investment portfolios, and deep industry expertise.

What is the significance of Hercules Capital, Inc. in the venture lending space?

Hercules Capital is a leading lender of choice for entrepreneurs and venture capital firms, highlighted by its extensive commitments and successful partnerships with high-growth companies.
Hercules Capital Inc

NYSE:HTGC

HTGC Rankings

HTGC Stock Data

3.76B
169.33M
1.76%
25.96%
3%
Asset Management
Financial Services
Link
United States
SAN MATEO